v3.25.2
Condensed Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Warrants
Additional Paid-In- Capital
Accumulated Deficit
Non- Controlling Interest
Beginning balance (in shares) at Dec. 31, 2023   29,364          
Beginning balance at Dec. 31, 2023 $ 14,093 $ 389 $ (116,701) $ 2,219 $ 462,583 $ (333,797) $ (600)
Net (loss) income (2,673)         (2,767) 94
Shares issued under equity compensation plan (in shares)   81          
Shares issued under equity compensation plan (665) $ 3 (665)   (3)    
Proceeds from exercise of warrants (in shares)   240          
Proceeds from exercise of warrants 1,309 $ 2   (474) 1,781    
Distributions to non-controlling interest (179)           (179)
Stock-based compensation expense 1,771       1,771    
Ending balance (in shares) at Mar. 31, 2024   29,685          
Ending balance at Mar. 31, 2024 13,656 $ 394 (117,366) 1,745 466,132 (336,564) (685)
Beginning balance (in shares) at Dec. 31, 2023   29,364          
Beginning balance at Dec. 31, 2023 14,093 $ 389 (116,701) 2,219 462,583 (333,797) (600)
Net (loss) income 32,247            
Ending balance (in shares) at Jun. 30, 2024   29,944          
Ending balance at Jun. 30, 2024 47,702 $ 397 (119,538) 1,745 467,550 (301,852) (600)
Beginning balance (in shares) at Mar. 31, 2024   29,685          
Beginning balance at Mar. 31, 2024 13,656 $ 394 (117,366) 1,745 466,132 (336,564) (685)
Net (loss) income 34,920         34,712 208
Shares issued under equity compensation plan (in shares)   345          
Shares issued under equity compensation plan (1,469) $ 3 (1,469)   (3)    
Distributions to non-controlling interest (123)           (123)
Stock-based compensation expense 1,421       1,421    
Repurchases of common stock (in shares)   (86)          
Repurchases of common stock (703)   (703)        
Ending balance (in shares) at Jun. 30, 2024   29,944          
Ending balance at Jun. 30, 2024 $ 47,702 $ 397 (119,538) 1,745 467,550 (301,852) (600)
Beginning balance (in shares) at Dec. 29, 2024 29,893 29,893          
Beginning balance at Dec. 29, 2024 $ 57,948 $ 398 (120,338) 1,745 470,085 (293,503) (439)
Net (loss) income 85         (62) 147
Shares issued under equity compensation plan (in shares)   114          
Shares issued under equity compensation plan (236) $ 1 (236)   (1)    
Proceeds from exercise of warrants 358 $ 1   (131) 488    
Distributions to non-controlling interest (222)           (222)
Stock-based compensation expense 1,548       1,548    
Repurchases of common stock (in shares)   (117)          
Repurchases of common stock (1,128)   (1,128)        
Ending balance (in shares) at Mar. 30, 2025   29,890          
Ending balance at Mar. 30, 2025 $ 58,353 $ 400 (121,702) 1,614 472,120 (293,565) (514)
Beginning balance (in shares) at Dec. 29, 2024 29,893 29,893          
Beginning balance at Dec. 29, 2024 $ 57,948 $ 398 (120,338) 1,745 470,085 (293,503) (439)
Net (loss) income $ 2,999            
Ending balance (in shares) at Jun. 29, 2025 30,256 30,256          
Ending balance at Jun. 29, 2025 $ 61,097 $ 406 (124,017) 1,437 474,606 (291,077) (258)
Beginning balance (in shares) at Mar. 30, 2025   29,890          
Beginning balance at Mar. 30, 2025 58,353 $ 400 (121,702) 1,614 472,120 (293,565) (514)
Net (loss) income 2,914         2,488 426
Shares issued under equity compensation plan (in shares)   479          
Shares issued under equity compensation plan (1,326) $ 5 (1,326)   (5)    
Proceeds from exercise of warrants 488 $ 1   (177) 664    
Distributions to non-controlling interest (170)           (170)
Stock-based compensation expense 1,827       1,827    
Repurchases of common stock (in shares)   (113)          
Repurchases of common stock $ (989)   (989)        
Ending balance (in shares) at Jun. 29, 2025 30,256 30,256          
Ending balance at Jun. 29, 2025 $ 61,097 $ 406 $ (124,017) $ 1,437 $ 474,606 $ (291,077) $ (258)